Cover Image

Short-Term Postoperative Cognitive Dysfunction and Inflammatory Response in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Pilot Study

Objectives. To assess the association between short-term postoperative cognitive dysfuction (POCD) and inflammtory response in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Design. A prospective cohort study. Setting. University medical centre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Yu (Author), Rui Dong (Author), Yayuan Lu (Author), Xi Yang (Author), Chang Chen (Author), Zongze Zhang (Author), Mian Peng (Author)
Format:	Book
Published:	Hindawi Limited, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019)

Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review
by: Denise Drittone, et al.
Published: (2024)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers
by: McKayla J. Riggs, et al.
Published: (2020)

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
by: Courtney A. Penn, et al.
Published: (2022)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy
by: Nishkarsh Gupta, et al.
Published: (2019)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019)

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials
by: Changchun Jian, et al.
Published: (2023)

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
by: Daan R. Löke, et al.
Published: (2021)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023)

Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report
by: K. Patel, et al.
Published: (2021)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
by: Kate Glennon, et al.
Published: (2021)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021)

Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
by: Laura M. Chambers, et al.
Published: (2022)

Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022)

Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Shalini Venkatappa, et al.
Published: (2022)

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary
by: Nicholas K. Larsen, et al.
Published: (2020)

Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
by: Laura M. Chambers, et al.
Published: (2021)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021)

Integration of monitoring aids: A scientific approach for better patient outcome during hyperthermic intraperitoneal chemotherapy
by: Rakhi Gupta, et al.
Published: (2017)

Quimioterapia hipertérmica intraperitoneal transoperatória: o que a enfermagem precisa saber [Intraoperative hyperthermic intraperitoneal chemotherapy: what nurses should know]
by: Rafael Tavares Jomar, et al.
Published: (2017)

Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
by: Daisuke Inoue, et al.
Published: (2015)

The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis
by: Zhixian Lin, et al.
Published: (2022)

Experimental study of metallothionein synthesis in modeling hyperthermic intraoperative intraperitoneal chemoperfusion with cysplatinum
by: E. D. Pykhtieieva, et al.
Published: (2018)

Experimental study of metallothionein synthesis in modeling hyperthermic intraoperative intraperitoneal chemoperfusion with cysplatinum
by: E. D. Pykhtieieva, et al.
Published: (2018)

Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels
by: Meiling Zhang, et al.
Published: (2023)

The Use of Gemcitabine and Docetaxel as a Novel Combination for Hyperthermic Intraperitoneal Chemotherapy in the Management of Recurrent Complicated Abdominal Sarcoma: Case Report and Review of Literature
by: Ayman Zaki Azzam, et al.
Published: (2024)

Intraoperative parameters and postoperative follow-up of foam-based intraperitoneal chemotherapy (FBIC)
by: Carolina Khosrawipour, et al.
Published: (2023)

Commment on the review entitled "A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer" by Chiva LM and Gonzalez-Martin A.
by: Marcello Deraco, et al.
Published: (2016)

Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Muenyi Clarisse S, et al.
Published: (2011)

Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma
by: Alexandre Brind'Amour, et al.
Published: (2020)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024)

The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial)
by: Qun Wang, et al.
Published: (2024)

Primary cytoreductive surgery or interval cytoreductive surgery
by: Yiu-Tai Li, et al.
Published: (2024)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
by: Amelia M. Jernigan, et al.
Published: (2013)

Restricted HIV-1 diversity and clonal expansion following cytoreductive chemotherapy
by: T.J. Henrich, et al.
Published: (2015)

Cognitive dysfunction in older patients undergoing non‐neurosurgery in the immediate postoperative period: A systematic review
by: Pinyapat Kitthanyateerakul, et al.
Published: (2024)

Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy
by: Milad Shamsi, et al.
Published: (2018)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
by: Maurie Markman
Published: (2009)